These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16387499)

  • 41. Novel N-substituted indol-3-ylglyoxylamides probing the LDi and L1/L2 lipophilic regions of the benzodiazepine receptor site in search for subtype-selective ligands.
    Primofiore G; Taliani S; Da Settimo F; Marini AM; La Motta C; Simorini F; Patrizi MP; Sergianni V; Novellino E; Greco G; Cosimelli B; Calderone V; Montali M; Besnard F; Martini C
    J Med Chem; 2007 Apr; 50(7):1627-34. PubMed ID: 17335185
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Contribution of lateral substituents in symmetrical and non-symmetrical heptane-bisammonio compounds to the allosteric stabilization of N-methylscopolamine binding to muscarinic M2 receptors.
    Staudt M; Tränkle C; Mohr K; Holzgrabe U
    Arch Pharm (Weinheim); 2003 Aug; 336(8):385-9. PubMed ID: 14502759
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Two-state models and the analysis of the allosteric effect of gallamine at the M2 muscarinic receptor.
    Ehlert FJ; Griffin MT
    J Pharmacol Exp Ther; 2008 Jun; 325(3):1039-60. PubMed ID: 18305010
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Discovery of potent cholecystokinin-2 receptor antagonists: elucidation of key pharmacophore elements by X-ray crystallographic and NMR conformational analysis.
    Rosen MD; Hack MD; Allison BD; Phuong VK; Woods CR; Morton MF; Prendergast CE; Barrett TD; Schubert C; Li L; Wu X; Wu J; Freedman JM; Shankley NP; Rabinowitz MH
    Bioorg Med Chem; 2008 Apr; 16(7):3917-25. PubMed ID: 18289861
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of M(1) muscarinic receptor subtype in rat stomach using a tissue segment binding method, and the effects of immobilization stress on the muscarinic receptors.
    Anisuzzaman AS; Morishima S; Suzuki F; Tanaka T; Muramatsu I
    Eur J Pharmacol; 2008 Dec; 599(1-3):146-51. PubMed ID: 18938154
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preparation and characterization of N-(3-pyridinyl) spirocyclic diamines as ligands for nicotinic acetylcholine receptors.
    Sippy KB; Anderson DJ; Bunnelle WH; Hutchins CW; Schrimpf MR
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1682-5. PubMed ID: 19232492
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structure/activity relationships of M2 muscarinic allosteric modulators.
    Mohr K; Tränkle C; Holzgrabe U
    Recept Channels; 2003; 9(4):229-40. PubMed ID: 12893536
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Positive homotropic allosteric binding of benzenediols in a hydrindacene-based exoditopic receptor: cooperativity in amide hydrogen bonding.
    Kawai H; Katoono R; Nishimura K; Matsuda S; Fujiwara K; Tsuji T; Suzuki T
    J Am Chem Soc; 2004 Apr; 126(16):5034-5. PubMed ID: 15099063
    [TBL] [Abstract][Full Text] [Related]  

  • 49. GABAA receptor pharmacology of fluorinated derivatives of the novel sedative-hypnotic pyrazolopyrimidine indiplon.
    Wegner F; Deuther-Conrad W; Scheunemann M; Brust P; Fischer S; Hiller A; Diekers M; Strecker K; Wohlfarth K; Allgaier C; Steinbach J; Hoepping A
    Eur J Pharmacol; 2008 Feb; 580(1-2):1-11. PubMed ID: 18035350
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Covalent modification of GABAA receptor isoforms by a diazepam analogue provides evidence for a novel benzodiazepine binding site that prevents modulation by these drugs.
    Baur R; Tan KR; Lüscher BP; Gonthier A; Goeldner M; Sigel E
    J Neurochem; 2008 Sep; 106(6):2353-63. PubMed ID: 18643789
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bisquaternary caracurine V derivatives as allosteric modulators of ligand binding to M2 acetylcholine receptors.
    Zlotos DP; Buller S; Tränkle C; Mohr K
    Bioorg Med Chem Lett; 2000 Nov; 10(22):2529-32. PubMed ID: 11086722
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 1-(2-Aminoethyl)-3-(arylsulfonyl)-1H-indoles as novel 5-HT6 receptor ligands.
    Bernotas R; Lenicek S; Antane S; Zhang GM; Smith D; Coupet J; Harrison B; Schechter LE
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5499-502. PubMed ID: 15482912
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phenylethyl-substituted pyrimido[2,1-f]purinediones and related compounds: structure-activity relationships as adenosine A(1) and A(2A) receptor ligands.
    Drabczyńska A; Müller CE; Schiedel A; Schumacher B; Karolak-Wojciechowska J; Fruziński A; Zobnina W; Yuzlenko O; Kieć-Kononowicz K
    Bioorg Med Chem; 2007 Nov; 15(22):6956-74. PubMed ID: 17827019
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Monoaryl-substituted salicylaldoximes as ligands for estrogen receptor beta.
    Minutolo F; Bellini R; Bertini S; Carboni I; Lapucci A; Pistolesi L; Prota G; Rapposelli S; Solati F; Tuccinardi T; Martinelli A; Stossi F; Carlson KE; Katzenellenbogen BS; Katzenellenbogen JA; Macchia M
    J Med Chem; 2008 Mar; 51(5):1344-51. PubMed ID: 18269232
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Monomers and oligomers of the M2 muscarinic cholinergic receptor purified from Sf9 cells.
    Park PS; Wells JW
    Biochemistry; 2003 Nov; 42(44):12960-71. PubMed ID: 14596611
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of a new type of allosteric modulator of muscarinic receptors: hybrids of the antagonist AF-DX 384 and the hexamethonio derivative W84.
    Mohr M; Heller E; Ataie A; Mohr K; Holzgrabe U
    J Med Chem; 2004 Jun; 47(12):3324-7. PubMed ID: 15163212
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differences in kinetics of xanomeline binding and selectivity of activation of G proteins at M(1) and M(2) muscarinic acetylcholine receptors.
    Jakubík J; El-Fakahany EE; Dolezal V
    Mol Pharmacol; 2006 Aug; 70(2):656-66. PubMed ID: 16675658
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discovery of indole-containing tetracycles as a new scaffold for androgen receptor ligands.
    Zhang X; Li X; Allan GF; Musto A; Lundeen SG; Sui Z
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3233-7. PubMed ID: 16603353
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dualsteric GPCR targeting and functional selectivity: the paradigmatic M(2) muscarinic acetylcholine receptor.
    Bock A; Mohr K
    Drug Discov Today Technol; 2013; 10(2):e245-52. PubMed ID: 24050275
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras.
    Tejada FR; Nagy PI; Xu M; Wu C; Katz T; Dorsey J; Rieman M; Lawlor E; Warrier M; Messer WS
    J Med Chem; 2006 Dec; 49(25):7518-31. PubMed ID: 17149881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.